Concept
Maladie congénitale
Personnes associées (23)
Alfredo Pasquarello
Alfredo Pasquarello effectue ses études en physique à l'Ecole normale supérieure de Pise et à l'Université de Pise et obtient leurs diplômes respectifs en 1986. Il obtient le titre de Docteur ès sciences à l'EPFL en 1991 avec une thèse portant sur les transitions à plusieurs photons dans les solides. Ensuite, il effectue des recherches post-doctorales aux Laboratoires Bell (Murray Hill, New Jersey) sur les propriétés magnétiques des fullerènes de carbone. En 1993, il rejoint l'Institut romand de recherche numérique en physique des matériaux (IRRMA), où sa recherche porte sur des méthodes de simulation ab initio. En 1998, le Prix Latsis de l'EPFL lui est decerné pour son travail de recherche portant sur les matériaux à base de silice désordonnée. Bénéficiant de plusieurs subsides du Fonds National, il constitue ensuite sa propre équipe de recherche à l'IRRMA. En juillet 2003, il est nommé Professeur en Physique théorique de la matière condensée à l'EPFL. Actuellement, il dirige la Chaire de simulation à l'échelle atomique.
Nava Setter
Nava Setter completed MSc in Civil Engineering in the Technion (Israel) and PhD in Solid State Science in Penn. State University (USA) (1980). After post-doctoral work at the Universities of Oxford (UK) and Geneva (Switzerland), she joined an R&D institute in Haifa (Israel) where she became the head of the Electronic Ceramics Lab (1988). She began her affiliation with EPFL in 1989 as the Director of the Ceramics Laboratory, becoming Full Professor of Materials Science and Engineering in 1992. She had been Head of the Materials Department in the past and more recently has served as the Director of the Doctoral School for Materials.
Research at the Ceramics Laboratory, which Nava Setter directs, concerns the science and technology of functional ceramics focusing on piezoelectric and related materials: ferroelectrics, dielectrics, pyroelectrics and also ferromagnetics. The work includes fundamental and applied research and covers the various scales from the atoms to the final devices. Emphasis is given to micro- and nano-fabrication technology with ceramics and coupled theoretical and experimental studies of the functioning of ferroelectrics.
Her own research interests include ferroelectrics and piezoelectrics: in particular the effects of interfaces, finite-size and domain-wall phenomena, as well as structure-property relations and the pursuit of new applications. The leading thread in her work over the years has been the demonstration of how basic or fundamental concepts in materials - particularly ferroelectrics - can be utilized in a new way and/or in new types of devices. She has published over 450 scientific and technical papers.
Nava Setter is a Fellow of the Swiss Academy of Technical Sciences, the Institute of Electrical and Electronic Engineers (IEEE), and the World Academy of Ceramics. Among the awards she received are the Swiss-Korea Research Award, the ISIF outstanding achievement award, and the Ferroelectrics-IEEE recognition award. In 2010 her research was recognized by the European Union by the award of an ERC Advanced Investigator Grant. Recently she received the IEEE-UFFC Achievement Award (2011),the W.R. Buessem Award(2011), the Robert S. Sosman Award Lecture (American Ceramics Society) (2013), and the American Vacuum Society Recognition for Excellence in Leadership (2013).
Dragan Damjanovic
Dragan Damjanovic received BSc diploma in Physics from the Faculty of Natural Sciences and Mathematics, University of Sarajevo, in 1980, and PhD in Ceramics Science from the Department of Materials Science and Engineering, College of Earth and Mineral Sciences, the Pennsylvania State University (PSU) in 1987. From 1988 to 1991 he was a research associate in the Materials Research Laboratory at the PSU. He joined the Ceramics Laboratory, Department of Materials Science and Engineering, Ecole polytechnique fédérale de Lausanne in 1991. He is currently a "professeur titulaire", heads the Group for Ferroelectrics and Functional Oxides at the Institute of Materials and teaches undergraduate and graduate courses on structure and electrical properties of materials. The research activities include fundamental and applied investigations of piezoelectric, ferroelectric and dielectric properties of a broad class of materials.
Oleg Yazyev
Prof. Oleg Yazyev (Олег Язев) was born in Simferopol, Crimean peninsula. He obtained his degree in chemistry from Moscow State University in 2003. He then joined Ecole Polytechnique Fédérale de Lausanne (EPFL) completing his PhD thesis in chemistry and chemical engineering in 2007. Next two years he has spent as a postdoctoral fellow at the Institute of Theoretical Physics (ITP) and the Institute for Numerical Research in the Physics of Materials (IRRMA) of the same institution. In 2009-2011 he was a postdoctoral fellow at the Department of Physics of the University of California, Berkeley and the Lawrence Berkeley National Laboratory. In September 2011 he started an independent research group supported by the Swiss National Science Foundation professorship grant. In 2012 he was awarded an ERC Starting grant. His current research focuses on theoretical and computational physics of the recently discovered Dirac fermion materials with strong emphasis on their prospective technological applications. ResearcherID profile of Oleg Yazyev
Dominique Pioletti
Dominique Pioletti received his Master in Physics from the Swiss Federal Institute of Technology Lausanne (EPFL) in 1992. He pursued his education in the same Institution and obtained his PhD in biomechanics in 1997. He developed original constitutive laws taking into account viscoelasticity in large deformations. Then he spent two years at UCSD as post-doc fellow acquiring know-how in cell and molecular biology. He was interested in particular to gene expression of bone cells in contact to orthopedic implant. In April 2006, Dominique Pioletti was appointed Assistant Professor tenure-track at the EPFL and is director of the Laboratory of Biomechanical Orthopedics. His research topics include biomechanics and tissue engineering of musculo-skeletal tissues; mechano-transduction in bone; development of orthopedic implant as drug delivery system. Since 2013, he has been promoted to the rank of Associate Professor.
Denis Duboule
Denis Duboule est né en 1955. De Nationalités Suisse et Française, il étudie la biologie à lUniversité de Genève où il reçoit un PhD dans le domaine de lembryologie des mammifères en 1984. Il passe ensuite 10 ans à létranger, dabord comme post-doc et group leader à la faculté de Médecine de Strasbourg (CNRS), puis au Laboratoire Européen de Biologie Moléculaire, à Heidelberg (Allemagne). En 1993, il est nommé Professeur ordinaire à lUniversité de Genève, où il dirige le département de Génétique et Evolution depuis 1997. En 2001 il prend la direction du pôle dexcellence NCCR aux Frontières de la Génétique et celle de la division médecine-Biologie du FNS en 2012. En 2006, il est nommé Professeur ordinaire à lEPFL, Lausanne, où il dirige le laboratoire de Génomique du Développement (UpDUB).
Ses activités de recherche sexercent dans le domaine de lembryologie, de la génétique et de la génomique du développement des mammifères, dans le contexte général de lEvolution des structures et des organes. En particulier, son laboratoire a été associé à de nombreuses recherches dans le domaine de lanalyse structurelle et fonctionnelle des gènes architectes (Hox) et de leur régulation transcriptionnelle pendant le développement précoce. Denis Duboule est également actif dans le domaine de la communication de la science. Il est membre de lAcademia Europea ainsi que dautres académies. Il est également membre de lInstitut de France (Académie des Sciences), de la Société Royale (UK) et de lAcadémie des Sciences Américaine (NAS). Il a reçu plusieurs prix et distinction, notamment le Prix Marcel Benoist, le Prix Louis-Jeantet de Médecine en 1998 et le Prix international de lINSERM en 2010. Voir également https://fr.wikipedia.org/wiki/Denis_Duboule.
Freddy Radtke
Freddy Radtke obtained his Ph.D. in Molecular Biology from the University of Zürich in 1994. In 1995, he started his postdoctoral research in the laboratory of Michel Aguet at Genentech, Inc. (San Francisco, USA). In 1997, he returned to Switzerland with Michel Aguet and finished his postdoctoral fellowship at the Swiss Institute for Experimental Cancer Research (ISREC) in Lausanne. From 1999‑2005, he was a group leader and Associate Member at the Ludwig Institute for Cancer Research. Freddy Radtke then joined ISREC in January 2006 as a senior scientist and in July 2006, he was appointed Associate Professor at the EPFL School of Life Sciences
Johan Auwerx
Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Cathrin Brisken
Cathrin Brisken, MD, PhD, is Associate Professor of Life Sciences at the Swiss Federal Institute of Technology Lausanne (EPFL). Dr. Brisken is internationally recognized for her work on endocrine control of mammary gland development and breast carcinogenesis.
Dr. Brisken received her MD and her PhD degree in Biophysics from the Georg August University of Göttingen, Germany. She completed her postdoctoral work in cancer biology with Dr. R.A. Weinberg at the Whitehead Institute of Biomedical Research in Cambridge, MA, USA. She previously held appointments at the Cancer Center of the Massachusetts General Hospital, Harvard Medical School, Boston and the Swiss Institute for Experimental Cancer Research (ISREC).
Research in Dr. Brisken’s laboratory focuses on the cellular and molecular underpinnings of estrogen and progesterone receptor signaling in the breast and the respective roles of these hormones and hormonally active compounds in carcinogenesis. The aim is to understand how recurrent exposures to endogenous and exogenous hormones contribute to breast carcinogenesis in order to better prevent and treat the disease. The laboratory has pioneered in vivo approaches to genetically dissect the role of the reproductive hormones in driving mouse mammary gland development and shown how they control intercellular communication. Dr. Brisken’s group has developed ex vivo and humanized mouse models using patient samples to study hormone action in human tissues in normal settings and during disease progression.
Dr. Brisken is member of the International Breast Cancer Study Group (IBCSG) Biological Protocol Working Group. She served as Dean of EPFL Doctoral School (more than 2000 PhD students in 18 PhD programs), as member of the Hinterzartener Kreis, the oncology think-tank associated with the German Science Foundation, and numerous Swiss, European, and AACR committees. She co-founded the International Cancer Prevention Institute.
Pierre Gönczy
Pierre Gönczy obtained his PhD from The Rockefeller University (New York, USA) in 1995 and joined the laboratory of Tony Hyman at the EMBL (Heidelberg, Germany) as a postdoctoral fellow in 1996. He started his own laboratory at ISREC in 2000. In 2005, he became Associate Professor at the EPFL School of Life Sciences, and was promoted Full Professor in 2009.